These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 26470691

  • 21. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY, Jung HU, Yoo SH, Yoo KS, Cheong J, Park BS, Yun I, Yoo YH.
    Cancer Lett; 2014 Dec 01; 355(1):61-9. PubMed ID: 25218348
    [Abstract] [Full Text] [Related]

  • 22. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.
    Liu J, Lian Z, Han S, Waye MM, Wang H, Wu MC, Wu K, Ding J, Arbuthnot P, Kew M, Fan D, Feitelson MA.
    Oncogene; 2006 Feb 16; 25(7):1008-17. PubMed ID: 16247464
    [Abstract] [Full Text] [Related]

  • 23. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S, Gao S, Zhao M, Liu Y, Bu Y, Jiang Q, Zhao Q, Ye L, Zhang X.
    Cancer Lett; 2017 Apr 28; 392():94-104. PubMed ID: 28192212
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.
    Wang C, Wang MD, Cheng P, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Wu MC, Zhou WP.
    Cell Death Dis; 2017 Jan 19; 8(1):e2560. PubMed ID: 28102846
    [Abstract] [Full Text] [Related]

  • 25. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y, Wang J, Wang Y, Wang A, Guo H, Wei F, Mehta SR, Espitia S, Smith DM, Liu L, Zhang Y, Chen D.
    Cancer Lett; 2016 Feb 28; 371(2):285-91. PubMed ID: 26706415
    [Abstract] [Full Text] [Related]

  • 26. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS, Xia N, Sun H, Kong Y.
    J Cell Mol Med; 2017 Nov 28; 21(11):3023-3043. PubMed ID: 28557334
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
    Guerrieri F, Belloni L, Pediconi N, Levrero M.
    Semin Liver Dis; 2013 May 28; 33(2):147-56. PubMed ID: 23749671
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.
    Oropeza CE, Ondracek CR, Tarnow G, Maienschein-Cline M, Green SJ, McLachlan A.
    Virology; 2022 Jan 28; 566():16-25. PubMed ID: 34844082
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, Zhou WP, Sun SH.
    Hepatology; 2013 May 28; 57(5):1882-92. PubMed ID: 23239537
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
    Lee WP, Lan KH, Li CP, Chao Y, Lin HC, Lee SD.
    Biochim Biophys Acta; 2016 Apr 28; 1862(4):837-849. PubMed ID: 26791804
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B virus-induced hepatocellular carcinoma.
    Xu C, Zhou W, Wang Y, Qiao L.
    Cancer Lett; 2014 Apr 10; 345(2):216-22. PubMed ID: 23981576
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
    Uchida T, Takahashi K, Tatsuno K, Dhingra U, Eliason JF.
    Int J Cancer; 1996 Sep 17; 67(6):892-7. PubMed ID: 8824564
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, Zhang X.
    Neoplasia; 2013 Nov 17; 15(11):1282-91. PubMed ID: 24339740
    [Abstract] [Full Text] [Related]

  • 37. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z, Huang P, Yan Y, Zhou Z, Wang J, Wu G.
    Biochem Biophys Res Commun; 2019 Jan 01; 508(1):79-86. PubMed ID: 30471857
    [Abstract] [Full Text] [Related]

  • 38. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH, Ai X, Liu FY, Liang HF, Zhang BX, Chen XP.
    Mol Med Rep; 2016 Feb 01; 13(2):1345-52. PubMed ID: 26648552
    [Abstract] [Full Text] [Related]

  • 39. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL, Wu ML.
    J Pathol; 2013 Aug 01; 230(4):377-87. PubMed ID: 23620081
    [Abstract] [Full Text] [Related]

  • 40. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
    Chen JS, Su IJ, Leu YW, Young KC, Sun HS.
    Int J Cancer; 2012 Mar 15; 130(6):1302-13. PubMed ID: 21469146
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.